Literature DB >> 2070821

Localization of hyaluronate in primary glial cell cultures derived from newborn rat brain.

R Asher1, A Bignami.   

Abstract

We have devised a technique that enables one to localize hyaluronate in cultured cells. Cells were probed with the glial hyaluronate binding protein (GHAP) which was itself then visualized by conventional indirect immunofluorescence. The hyaluronate binding properties of this protein have been established. This technique was applied to the study of hyaluronate synthesis in glial cells. These cells do not themselves produce GHAP. O-2A progenitor cells were obtained from the cerebral hemispheres of newborn rats. These cells are bipotential in that they are able to differentiate into either oligodendrocytes or type 2 astrocytes depending on the composition of the culture medium. In cultures of O-2A progenitor cells maintained in the absence of serum, in which large numbers of oligodendrocytes appeared, very little hyaluronate was produced. The galC+ cells were invariably hyaluronate negative. Cultures of the same cells, maintained in the presence of 10% FCS, contained large numbers of hyaluronate producing cells. The hyaluronate producing cells were typically small, process-bearing, and GFAP+. Some, but not all, were A2B5+ and could, therefore, be identified as type 2 (GFAP+, A2B5+) astrocytes. Type 1 (GFAP+, A2B5-) astrocytes were also active in the synthesis of hyaluronate, to the extent that they were able to coat their substrate with hyaluronate. Among cells of the O-2A lineage, then, hyaluronate production would appear to be restricted to astrocytes. This may have some bearing on the origin of hyaluronate in the extracellular matrix of CNS white matter.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2070821     DOI: 10.1016/0014-4827(91)90390-g

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  Neurocan is upregulated in injured brain and in cytokine-treated astrocytes.

Authors:  R A Asher; D A Morgenstern; P S Fidler; K H Adcock; A Oohira; J E Braistead; J M Levine; R U Margolis; J H Rogers; J W Fawcett
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

Review 2.  Expression of the CD44 adhesion molecule in tumours of the central and peripheral nervous system.

Authors:  G H Baltuch; N de Tribolet; E G Van Meir
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

3.  Neurons produce a neuronal cell surface-associated chondroitin sulfate proteoglycan.

Authors:  C Lander; H Zhang; S Hockfield
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

4.  Hyaline cartilage tissue is formed through the co-culture of passaged human chondrocytes and primary bovine chondrocytes.

Authors:  Drew W Taylor; Nazish Ahmed; Anthony J Hayes; Peter Ferguson; Allan E Gross; Bruce Caterson; Rita A Kandel
Journal:  J Histochem Cytochem       Date:  2012-05-19       Impact factor: 2.479

Review 5.  Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix.

Authors:  A Bignami; M Hosley; D Dahl
Journal:  Anat Embryol (Berl)       Date:  1993-11

6.  Anti-(glioma surface antigen) monoclonal antibody G-22 recognizes overexpressed CD44 in glioma cells.

Authors:  H Okada; J Yoshida; H Seo; T Wakabayashi; K Sugita; M Hagiwara
Journal:  Cancer Immunol Immunother       Date:  1994-11       Impact factor: 6.968

7.  Hyaluronan synthesis by developing cortical neurons in vitro.

Authors:  Tania M Fowke; Rashika N Karunasinghe; Ji-Zhong Bai; Shawn Jordan; Alistair J Gunn; Justin M Dean
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

Review 8.  Diverse Roles for Hyaluronan and Hyaluronan Receptors in the Developing and Adult Nervous System.

Authors:  Alec Peters; Larry S Sherman
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923

9.  Inhibitor of Hyaluronic Acid Synthesis 4-Methylumbelliferone as an Anti-Inflammatory Modulator of LPS-Mediated Astrocyte Responses.

Authors:  Dmitry V Chistyakov; Arina I Nikolskaya; Sergei V Goriainov; Alina A Astakhova; Marina G Sergeeva
Journal:  Int J Mol Sci       Date:  2020-11-02       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.